Optimal defense strategy: Storage vs. new production

Emi Shudo, Yoh Iwasa

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

If hosts produce defense proteins after they are infected by pathogens, it may take hours to days before defense becomes fully active. By producing defense proteins beforehand, and storing them until infection, the host can cope with pathogens with a short time delay. However, producing and storing defense proteins require energy, and the activated defense proteins often cause harm to the host's body as well as to pathogens. Here, we study the optimal strategy for a host who chooses the amount of stored defense proteins, the activation of the stored proteins upon infection, and the new production of the proteins. The optimal strategy is the one that minimizes the sum of the harm by pathogens and the cost of defense. The host chooses the storage size of defense proteins based on the probability distribution of the magnitude of pathogen infection. When the infection size is predictable, all the stored proteins are to be activated upon infection. The optimal strategy is to have no storage and to rely entirely on new production if the expected infection size n0 is small, but to have a big storage without new production if n0 is large. The transition from the "new production" phase to "storage" phase occurs at a smaller n0 when storage cost is small, activation cost is large, pathogen toxicity is large, pathogen growth is fast, the defense is effective, the delay is long, and the infection is more likely. On the other hand, the storage size to produce for a large n0 decreases with three cost parameters and the defense effectiveness, increases with the likelihood of infection, the toxicity and the growth rate of pathogens, and it is independent of the time delay. When infection size is much smaller than the expected size, some of the stored proteins may stay unused.

Original languageEnglish
Pages (from-to)309-323
Number of pages15
JournalJournal of Theoretical Biology
Volume219
Issue number3
DOIs
Publication statusPublished - Jan 1 2002

Fingerprint

Pathogens
Infection
Proteins
Protein
pathogens
infection
proteins
Optimal Strategy
Costs and Cost Analysis
Costs
Toxicity
Activation
Time Delay
Time delay
Choose
Chemical activation
Strategy
toxicity
probability distribution
Growth

All Science Journal Classification (ASJC) codes

  • Statistics and Probability
  • Modelling and Simulation
  • Biochemistry, Genetics and Molecular Biology(all)
  • Immunology and Microbiology(all)
  • Agricultural and Biological Sciences(all)
  • Applied Mathematics

Cite this

Optimal defense strategy : Storage vs. new production. / Shudo, Emi; Iwasa, Yoh.

In: Journal of Theoretical Biology, Vol. 219, No. 3, 01.01.2002, p. 309-323.

Research output: Contribution to journalArticle

Shudo, Emi ; Iwasa, Yoh. / Optimal defense strategy : Storage vs. new production. In: Journal of Theoretical Biology. 2002 ; Vol. 219, No. 3. pp. 309-323.
@article{6c3f3103dae04e25b5be5ed1daba5726,
title = "Optimal defense strategy: Storage vs. new production",
abstract = "If hosts produce defense proteins after they are infected by pathogens, it may take hours to days before defense becomes fully active. By producing defense proteins beforehand, and storing them until infection, the host can cope with pathogens with a short time delay. However, producing and storing defense proteins require energy, and the activated defense proteins often cause harm to the host's body as well as to pathogens. Here, we study the optimal strategy for a host who chooses the amount of stored defense proteins, the activation of the stored proteins upon infection, and the new production of the proteins. The optimal strategy is the one that minimizes the sum of the harm by pathogens and the cost of defense. The host chooses the storage size of defense proteins based on the probability distribution of the magnitude of pathogen infection. When the infection size is predictable, all the stored proteins are to be activated upon infection. The optimal strategy is to have no storage and to rely entirely on new production if the expected infection size n0 is small, but to have a big storage without new production if n0 is large. The transition from the {"}new production{"} phase to {"}storage{"} phase occurs at a smaller n0 when storage cost is small, activation cost is large, pathogen toxicity is large, pathogen growth is fast, the defense is effective, the delay is long, and the infection is more likely. On the other hand, the storage size to produce for a large n0 decreases with three cost parameters and the defense effectiveness, increases with the likelihood of infection, the toxicity and the growth rate of pathogens, and it is independent of the time delay. When infection size is much smaller than the expected size, some of the stored proteins may stay unused.",
author = "Emi Shudo and Yoh Iwasa",
year = "2002",
month = "1",
day = "1",
doi = "10.1006/jtbi.2002.3126",
language = "English",
volume = "219",
pages = "309--323",
journal = "Journal of Theoretical Biology",
issn = "0022-5193",
publisher = "Academic Press Inc.",
number = "3",

}

TY - JOUR

T1 - Optimal defense strategy

T2 - Storage vs. new production

AU - Shudo, Emi

AU - Iwasa, Yoh

PY - 2002/1/1

Y1 - 2002/1/1

N2 - If hosts produce defense proteins after they are infected by pathogens, it may take hours to days before defense becomes fully active. By producing defense proteins beforehand, and storing them until infection, the host can cope with pathogens with a short time delay. However, producing and storing defense proteins require energy, and the activated defense proteins often cause harm to the host's body as well as to pathogens. Here, we study the optimal strategy for a host who chooses the amount of stored defense proteins, the activation of the stored proteins upon infection, and the new production of the proteins. The optimal strategy is the one that minimizes the sum of the harm by pathogens and the cost of defense. The host chooses the storage size of defense proteins based on the probability distribution of the magnitude of pathogen infection. When the infection size is predictable, all the stored proteins are to be activated upon infection. The optimal strategy is to have no storage and to rely entirely on new production if the expected infection size n0 is small, but to have a big storage without new production if n0 is large. The transition from the "new production" phase to "storage" phase occurs at a smaller n0 when storage cost is small, activation cost is large, pathogen toxicity is large, pathogen growth is fast, the defense is effective, the delay is long, and the infection is more likely. On the other hand, the storage size to produce for a large n0 decreases with three cost parameters and the defense effectiveness, increases with the likelihood of infection, the toxicity and the growth rate of pathogens, and it is independent of the time delay. When infection size is much smaller than the expected size, some of the stored proteins may stay unused.

AB - If hosts produce defense proteins after they are infected by pathogens, it may take hours to days before defense becomes fully active. By producing defense proteins beforehand, and storing them until infection, the host can cope with pathogens with a short time delay. However, producing and storing defense proteins require energy, and the activated defense proteins often cause harm to the host's body as well as to pathogens. Here, we study the optimal strategy for a host who chooses the amount of stored defense proteins, the activation of the stored proteins upon infection, and the new production of the proteins. The optimal strategy is the one that minimizes the sum of the harm by pathogens and the cost of defense. The host chooses the storage size of defense proteins based on the probability distribution of the magnitude of pathogen infection. When the infection size is predictable, all the stored proteins are to be activated upon infection. The optimal strategy is to have no storage and to rely entirely on new production if the expected infection size n0 is small, but to have a big storage without new production if n0 is large. The transition from the "new production" phase to "storage" phase occurs at a smaller n0 when storage cost is small, activation cost is large, pathogen toxicity is large, pathogen growth is fast, the defense is effective, the delay is long, and the infection is more likely. On the other hand, the storage size to produce for a large n0 decreases with three cost parameters and the defense effectiveness, increases with the likelihood of infection, the toxicity and the growth rate of pathogens, and it is independent of the time delay. When infection size is much smaller than the expected size, some of the stored proteins may stay unused.

UR - http://www.scopus.com/inward/record.url?scp=0036428740&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036428740&partnerID=8YFLogxK

U2 - 10.1006/jtbi.2002.3126

DO - 10.1006/jtbi.2002.3126

M3 - Article

C2 - 12419660

AN - SCOPUS:0036428740

VL - 219

SP - 309

EP - 323

JO - Journal of Theoretical Biology

JF - Journal of Theoretical Biology

SN - 0022-5193

IS - 3

ER -